Skip to content

BCTX

BriaCell Therapeutics Corp.

NASDAQ · Healthcare · Biotechnology · CA

$4.21
−0.24%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+40.9%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
May 20, 2024Lustig Marc · director, 10 percent owner: Purchase902,935$2.21
Dec 28, 2022Bondarenko Jamieson · officer: ChairmanPurchase28,000$4.58
Dec 28, 2022Williams William V. · officer: President, CEOPurchase2,530$1.94
Dec 20, 2022Bondarenko Jamieson · directorPurchase22,000$5.35
Institutional positioning

13F filings over the trailing two quarters

New 9Increased 7Reduced 5Sold out 1
FilerActionSharesFiled
CABLE CAR CAPITAL LLCNew Position216,821May 15, 2026
Cable Car Capital, LPUnchanged216,821Aug 14, 2026
SABBY MANAGEMENT, LLCIncreased80,721Aug 14, 2026
SABBY MANAGEMENT, LLCNew Position73,915May 15, 2026
IRIDIAN ASSET MANAGEMENT LLC/CTNew Position65,000Apr 24, 2026
IRIDIAN ASSET MANAGEMENT LLC/CTUnchanged65,000Jul 29, 2026
UBS Group AGIncreased43,642Aug 13, 2026
LuminArx Capital Management LPIncreased40,000Aug 14, 2026
HRT FINANCIAL LPNew Position34,904Aug 14, 2026
JANE STREET GROUP, LLCNew Position26,515Aug 14, 2026
LuminArx Capital Management LPNew Position15,000May 14, 2026
UBS GROUP AGIncreased11,541May 5, 2026
MORGAN STANLEYReduced3,021May 15, 2026
NATIONAL BANK OF CANADA /FI/Increased1,803Aug 10, 2026
MORGAN STANLEYReduced1,033Aug 13, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 20, 2024